Barrett, Terrance D.
Janssen Research & Development (United States)
3 papers on CoChatORCID 0000-0002-0850-8365
Most cited papers
- Verified
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
Perkovic, V., de Zeeuw, D., Mahaffey, K. W., Fulcher, G., Erondu, N., Shaw, W., Barrett, T. D., Weidner-Wells, M., Deng, H., Matthews, D. R., et al. (2018) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 637
- Verified
Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program
Rådholm, K., Figtree, G., Perkovic, V., Solomon, S. D., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Barrett, T. D., Shaw, W., Desai, M., et al. (2018) · Circulation
Diabetes Treatment and ManagementHeart Failure Treatment and Management
Cited by 488
- Verified
Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
Barrett, T. D., Palomino, H. L., Brondstetter, T. I., Kanelakis, K. C., Wu, X., Haug, P. V., Yan, W., Young, A., Hua, H., Hart, J. C., et al. (2011) · Molecular Pharmacology
Erythropoietin and Anemia TreatmentCancer, Hypoxia, and Metabolism
Cited by 78
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free